A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers

Clinical trial NCT05033444 · COMPLETED

Trial details

NCT number: NCT05033444
Sponsor: Odyssey Group International, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Traumatic Brain Injury (TBI)

Start date: 2022-02-09
Primary completion: 2022-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.